17β-Estradiol-mediated growth inhibition of MDA-MB-468 cells stably transfected with the estrogen receptor: Cell cycle effects
- 30 September 1997
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 133 (1) , 49-62
- https://doi.org/10.1016/s0303-7207(97)00142-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cellsMolecular Endocrinology, 1996
- Growth Factors in Breast CancerEndocrine Reviews, 1995
- Different Response of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-Sensitive Genes in Human Breast Cancer MCF-7 and MDA-MB 231 CellsArchives of Biochemistry and Biophysics, 1995
- A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analogMolecular Endocrinology, 1995
- Growth Factor Synthesis and Human Breast Cancer ProgressionJNCI Journal of the National Cancer Institute, 1995
- Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progressionBreast Cancer Research and Treatment, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Anti-Epidermal Growth Factor Receptor Antibodies Inhibit the Autocrine-Stimulated Growth of MDA-468 Human Breast Cancer CellsMolecular Endocrinology, 1989
- Endocrine therapy of human breast cancer grown in nude miceBreast Cancer Research and Treatment, 1987
- MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGFBiochemical and Biophysical Research Communications, 1985